Published in

Taylor and Francis Group, Cancer Biology & Therapy, 2(11), p. 177-183

DOI: 10.4161/cbt.11.2.13839

Links

Tools

Export citation

Search in Google Scholar

Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: A GEMCAD study

Journal article published in 2011 by Carlos Hörndler, Rosa Gallego, Xabier García-Albeniz, Virginia Alonso-Espinaco, Vicente Alonso, Pilar Escudero, Mireya Jimeno, Javier Ortego, Jordi Codony-Servat, Carlos Fernández-Martos, Ana Calatrava, Mercedes Marín-Aguilera, Jenifer Muñoz, Sergi Castellví-Bel, Antoni Castells and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO